Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

BIOFLOW-III satellite-One-year clinical outcomes of diabetic patients treated with a biodegradable polymer sirolimus-eluting stent and comprehensive medical surveillance.

Kornowski R, Roguin A, Danenberg H, Assa HV, Abergel E, Rozenbaum E, Guetta V, Landes U, Jabara R, Merdler A, Segev A, Mosseri M, Assali A.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5):338-343. doi: 10.1016/j.carrev.2017.02.016. Epub 2017 Feb 21.

PMID:
28302466
2.

Ethnic disparity in the clinical characteristics of patients with heart failure.

Gotsman I, Avishai-Eliner S, Jabara R, Zemora Z, Shauer A, Lotan C, Keren A.

Eur J Heart Fail. 2015 Aug;17(8):801-8. doi: 10.1002/ejhf.285. Epub 2015 May 20.

3.

Clinical outcome of patients with chronic heart failure followed in a specialized heart failure center.

Gotsman I, Zwas D, Zemora Z, Jabara R, Admon D, Lotan C, Keren A.

Isr Med Assoc J. 2011 Aug;13(8):468-73.

4.

Safety and efficacy of frequency domain optical coherence tomography in pigs.

Li X, Villard JW, Ouyang Y, Michalek JE, Jabara R, Sims D, Kemp N, Glynn T, Banas C, Bailey SR, Feldman MD.

EuroIntervention. 2011 Aug;7(4):497-504. doi: 10.4244/EIJV7I4A80.

5.

A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries.

Jabara R, Geva S, Ribeiro HB, Chen JP, Hou D, Li J, King SB, Chronos N, Robinson KA.

EuroIntervention. 2009 Nov;5(5):619-26.

PMID:
20142184
6.

Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.

Jabara R, Pendyala L, Geva S, Chen J, Chronos N, Robinson K.

EuroIntervention. 2009 Dec 15;5 Suppl F:F58-64. doi: 10.4244/EIJV5IFA10.

PMID:
22100678
7.

Effect of gradual computerized angioplasty on outcomes of patients undergoing coronary stenting.

Leibowitz D, Lotan C, Katz I, Nassar H, Boguslavsky L, Mosseri M, Jabara R, Varshitzsky B, Danenberg H, Weiss AT.

Am J Cardiol. 2009 Jul 15;104(2):223-6. doi: 10.1016/j.amjcard.2009.03.035. Epub 2009 Jun 3.

PMID:
19576351
8.

Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.

Jabara R, Gadesam RR, Pendyala LK, Knopf WD, Chronos N, Chen JP, Viel K, King SB 3rd, Manoukian SV.

Am J Cardiol. 2009 Jun 15;103(12):1657-62. doi: 10.1016/j.amjcard.2009.02.039. Epub 2009 Apr 16.

PMID:
19539072
9.

Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents.

Li J, Jabara R, Pendyala L, Otsuka Y, Shinke T, Hou D, Robinson K, Chronos N.

JACC Cardiovasc Interv. 2008 Jun;1(3):279-85. doi: 10.1016/j.jcin.2008.01.009.

10.

Comparison of the clinical characteristics of apical and non-apical variants of "broken heart" (takotsubo) syndrome in the United States.

Jabara R, Gadesam R, Pendyala L, Chronos N, King SB, Chen JP.

J Invasive Cardiol. 2009 May;21(5):216-22.

PMID:
19411722
11.

Clinical and angiographic features of small vessel stenting in the drug-eluting stent era.

Jabara R, Gradman M, Chen JP, King SB 3rd, Gadesam R, Chronos NA.

Clin Cardiol. 2009 Jun;32(6):E40-5. doi: 10.1002/clc.20373.

12.

Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.

Pendyala L, Jabara R, Robinson K, Chronos N.

J Interv Cardiol. 2009 Feb;22(1):37-48. doi: 10.1111/j.1540-8183.2009.00423.x. Review.

PMID:
19281521
13.

Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study).

Jabara R, Gadesam R, Pendyala L, Chronos N, Crisco LV, King SB, Chen JP.

Am Heart J. 2008 Dec;156(6):1141-6. doi: 10.1016/j.ahj.2008.07.018. Epub 2008 Oct 9.

PMID:
19033010
14.

Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.

Shinke T, Geva S, Pendyala L, Jabara R, Li J, Chen JP, Venegoni A, Colley K, Klein R, Chronos N, Robinson K, Hou D.

Int J Cardiol. 2009 Jun 12;135(1):93-101. doi: 10.1016/j.ijcard.2008.06.030. Epub 2008 Aug 9.

PMID:
18692915
15.

High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries.

Shinke T, Li J, Chen JP, Pendyala L, Goodchild T, Jabara R, Geva S, Ueno T, Chronos N, Robinson K, Hou D.

Circ Cardiovasc Interv. 2008 Aug;1(1):28-35. doi: 10.1161/CIRCINTERVENTIONS.108.770008.

16.

Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.

Jabara R, Chronos N, Robinson K.

Catheter Cardiovasc Interv. 2008 Aug 1;72(2):186-94. doi: 10.1002/ccd.21607.

PMID:
18651646
17.

Drug-eluting stents: present and future.

Pendyala L, Jabara R, Shinke T, Chronos N, Robinson K, Li J, Hou D.

Cardiovasc Hematol Agents Med Chem. 2008 Apr;6(2):105-15. Review.

PMID:
18473775
18.

Review of percutaneous therapy for bifurcation lesions in the era of drug-eluting stents.

Pendyala L, Jabara R, Hou D, Shinke T, Li J, Gadesam R, Robinson K, Chronos N, Chen JP.

Minerva Cardioangiol. 2008 Feb;56(1):89-105. Review.

PMID:
18432172
19.

Late angiographic stent thrombosis: the LAST straw for drug-eluting stents?

Chen JP, Crisco LV, Jabara R, King SB 3rd.

Angiology. 2008 Dec-2009 Jan;59(6):667-75. doi: 10.1177/0003319707310279. Epub 2008 Apr 2.

PMID:
18388045
20.

Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.

Jabara R, Chronos N, Conway D, Molema W, Robinson K.

JACC Cardiovasc Interv. 2008 Feb;1(1):81-7. doi: 10.1016/j.jcin.2007.11.009.

Supplemental Content

Loading ...
Support Center